Roche and Discuva extend agreement to develop target antimicrobials
February 22, 2017Research and Development, Sales and Marketing Discuva, Roche
Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
Rabbit virus proves effective in treatment of multiple myeloma
February 22, 2017Research and Development multiple myeloma
A team of researchers at the Medical University of South Carolina (MUSC) utilising the myxoma virus (MYXV) to treat multiple …
Testosterone gel trials reveal mixed results of benefits and drawbacks
February 22, 2017Research and Development Testosterone gel, testosterone
A large study looking into the potential positive or negative effects of supplementing older men with testosterone gel revealed definitive …
Nativis bolsters boardroom with new director
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis
Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …
The March 2017 issue of Pharmafocus is now live!
February 22, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo
The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …
FDA Priority Review for Pfizer investigational leukaemia drug
February 22, 2017Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review
Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …
FDA rejects Amphastar’s application for NDA for intranasal overdose treatment
February 21, 2017Research and Development Amphastar, FDA
Amphastar has received a Complete Response Letter (CRL) for its New Drug Application (NDA) for an intranasal version of Naloxone, …
Anti-aging study reveals role of mitochondria pointing towards new medicine
February 21, 2017Manufacturing and Production, Research and Development Anti-aging, SkQ1, anti aging, mitochondria
A joint study between researchers from Russia and Sweden has revealed the extent to which mitochondria play a role in …
NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx
February 21, 2017Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen
NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …
Faulty batch of Takeda’s paracetamol discovered in Denmark
February 21, 2017Manufacturing and Production Denmark, Takeda
Takeda has announced a recall of a batch of its paracetamol tablets, named Pamol, in Denmark after two packs were …
Merck eyes new India bio-production facility
February 21, 2017Manufacturing and Production Merck
German pharmaceutical firm Merck has made it known that it has plans to expand its operations in India with a …
Amygdala acquires Gilead’s candidate for addiction treatment
February 20, 2017Manufacturing and Production, Sales and Marketing Amygdala, Gilead
Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …
BlackThorn Therapeutics bring in new CEO
February 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics
BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
Generic version of top-selling lung cancer drug hits Chinese market
February 20, 2017Sales and Marketing China, generics
A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …
Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis
February 20, 2017Research and Development, Sales and Marketing Celgene, multiple sclerosis
Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
Cardiovascular disease expected to place $1 trillion cost burden on US
February 20, 2017Medical Communications, Sales and Marketing cardiovascular disease
A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …
AstraZeneca sells off cancer drug to TerSera for $250 million
February 20, 2017Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex
AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …
Rise of superbugs in hospitals down to cutting cleaners’ jobs, suggests GMB
February 20, 2017Sales and Marketing GMB, MRSA, NHS, Superbugs
The rising numbers in those exposed to superbugs, such as E.coli and MRSA, is due to the cuts in the …
New Managing Director of UK & Ireland for Novartis
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis
Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …
Top Ten most popular articles on Pharmafile.com this week
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
Latest content
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
